Myelin oligodendrocyte glycoprotein-35-55 peptide induces severe chronic experimental autoimmune encephalomyelitis in HLA-DR2-transgenic mice.
The use of HLA class II-transgenic (Tg) mice has facilitated identification of antigenic T cell epitopes that may contribute to inflammation in T cell-mediated diseases such as rheumatoid arthritis and multiple sclerosis (MS). In this study, we compared the encephalitogenic activity of three DR2-res...
Main Authors: | Rich, C, Link, J, Zamora, A, Jacobsen, H, Meza-Romero, R, Offner, H, Jones, R, Burrows, G, Fugger, L, Vandenbark, A |
---|---|
Format: | Journal article |
Language: | English |
Published: |
2004
|
Similar Items
-
Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice.
by: Vandenbark, A, et al.
Published: (2003) -
Efficient presentation of myelin oligodendrocyte glycoprotein peptides but not protein by astrocytes from HLA-DR2 and HLA-DR4 transgenic mice.
by: Kort, J, et al.
Published: (2006) -
Myelin Oligodendrocyte Glycoprotein 35-55 (MOG 35-55)-induced Experimental Autoimmune Encephalomyelitis: A Model of Chronic Multiple Sclerosis
by: Sakie Miyamura, et al.
Published: (2019-12-01) -
Myelin oligodendrocyte glycoprotein encephalomyelitis: An unusual cause of blindness
by: Nimrat Sandhu, et al.
Published: (2022-01-01) -
Characterization of myelin oligodendrocyte glycoprotein (MOG)35–55-specific CD8+ T cells in experimental autoimmune encephalomyelitis
by: Yong Peng, et al.
Published: (2019-12-01)